Centre Hospitalier Regional Universitaire de Tours (CHRU de Tours) - Hopital Bretonneau

Tours 37044

0 studies enrolling now · 2 studies all time

What they study most

Antibody-mediated Rejection, Follicular Lymphoma, Non-Hodgkin Lymphoma

Studies at this site

• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma — Completed